InmunoTek, S.L.
UkraineAll drugs from this manufacturer
-
The drug is used for allergen-specific immunotherapy in the treatment of allergic rhinitis and rhinoconjunctivitis.
Dosage form: suspension, for subcutaneous administration
Active substance Dosage mixture of gluteraldehyde-polymerized allergen extracts 2000 IU/ml or 10 000 IU/ml ATC: V01AA
-
The drug is used for allergen-specific immunotherapy in the treatment of allergic rhinitis and rhinoconjunctivitis.
Dosage form: suspension, for subcutaneous administration
Active substance Dosage mixture of gluteraldehyde-polymerized allergen extracts 2000 IU/ml or 10 000 IU/ml ATC: V01AA
-
The drug is indicated for adults and children (from 6 months of age) for the prevention of recurrent bacterial respiratory tract infections.
Dosage form: spray, sublingual, suspension
Active substance Dosage mixture of inactivated bacterial strains s epidermidis s aureus s pneumoniae h influenzae m catarrhalis k pneumoniae 300 FTU/ml ATC: J07AX
-
The drug is used for immunotherapy of respiratory allergies in patients presenting with symptoms of rhinitis or rhinoconjunctivitis and confirmed allergy (positive skin tests or specific IgE tests).
Dosage form: spray, sublingual
Active substance Dosage mixture of gluteraldehyde-polymerized allergen extracts 30000 IU/ml ATC: V01AA20
-
The drug is used for immunotherapy of respiratory allergies in patients who exhibit allergy symptoms (e.g., rhinitis) and have a confirmed reaction to specific allergens via skin tests or blood tests.
Dosage form: spray, sublingual
Active substance Dosage mixture of extracts of natural allergens 30000 IU/ml ATC: V01AA
-
The drug is intended for adults for the prevention of recurrent bacterial urinary tract infections.
Dosage form: spray, sublingual, suspension
Active substance Dosage mixture of inactivated bacterial strains escherichia coli klebsiella pneumoniae enterococcus faecalis and proteus vulgaris 300 FTU/ml ATC: J07AX